Repeat Business Rate
Clients value Linical’s flexible and strategic approach to oncology trials, and >85% of Linical’s clients return to us for their next study.
You require a partner that will reliably deliver and assist you in navigating the complexity of oncology clinical trial development and execution. From Phase I-IV, we have optimized our oncology service offering by dedicating staff, technology, and assets to provide you with reliable and transparent access to data to facilitate decision making. Our robust team member experience ensures exceptional execution in all development operations while offering flexible solutions to meet your specific needs. Linical is the dedicated partner you can count on before, during, and after your oncology clinical trial, as we share a common goal of helping your compound succeed.
Linical offers experienced oncology project teams across the globe ready to support your next oncology clinical study. Expertise with your specific oncology indication is critically important when selecting the right partner for clinical trial conduct. Having completed hundreds of cancer clinical trials, our team is well positioned to leverage their experience to advance your development. Oncology is complex; each indication has its own nuances and challenges to surmount, and selecting the right oncology CRO for your next study requires a partner that can provide focus and dedication to you and your team. We have worked on cancer studies with a diverse range of patient populations and have built a strong network of investigator sites to support these trials. Explore more of Linical's oncology CRO specialities below.
Linical excels in solid tumor clinical trials, spanning many types of cancer. With 20+ years of experience running oncology studies, we have therapeutically aligned project teams that add value to your trial every step of the way.
Our solid tumor oncology experience includes Phase I-IV clinical trials across the globe, in key indications such as:
Linical has experience conducting hematology clinical trials across the globe in a variety of indications and patient populations.
Our hematology CRO experience encompasses many types of liquid tumors and hematological malignancies including:
More frequently, cancer therapies are targeting small subsets of patients with rare mutations or patients that have been treated with a very specific therapeutic regimen. Linical has experience supporting many types of cancer therapies and programs of varying complexity, including:
Linical also differentiates itself from other oncology CROs by excelling in early phase oncology clinical research (Phase I-II). Our unique early phase oncology solutions enable rapid study start up, drive operational efficiency, and get you to key inflection points faster.
“We love working with Linical across our development programs. They have been a true partner that collaborates effectively with our team and aligns with our goals.”
Clients value Linical’s flexible and strategic approach to oncology trials, and >85% of Linical’s clients return to us for their next study.
Linical excels at complex trials, and more than 20% of our oncology experience is with rare cancers. We understand the special demands of these trials and provide innovative solutions to succeed.
For Linical, oncology clinical research is personal, and many of our team members have dedicated their entire careers to oncology research or clinical care. This means our project teams are deeply knowledgeable of the complexities of oncology trials and passionate about overcoming challenges. We understand the importance of your trial and the impact it can have on patients across the globe. Our dedicated oncology project teams roll over from study to study together, giving your trial continuity and our undivided attention.
We have proven experience expertly navigating all stages of oncology clinical development, from trial planning to study conduct and product launch. Our full range of oncology CRO services even includes rescue studies, and clients love Linical’s innovative approaches to even the most challenges indications.
Linical provides comprehensive solutions for drug development strategy, including regulatory affairs, protocol development and study design, medical writing, and quality assurance.Through assessing scientific, regulatory, and commercial considerations, Linical works in collaboration with clients to optimize your trial’s drug development strategy.
Linical’s comprehensive clinical trial management services are designed to help your program achieve high-quality data, on time and on budget. From study start up and feasibility, to project management, biometrics, and drug safety, Linical has the flexibility and experience you need.
Don’t let the complex clinical development journey hold you back. With Linical, you can overcome obstacles, save valuable time and money, and reach your goals.
We start by listening to your needs and understanding your goals to ensure we’re the right CRO for you.
We propose solutions that proactively tackle obstacles, optimize your trial design, and position you for success every step of the way.
We’ll guide you through each phase of the process, offering personalized support and a full range of services to help you achieve a successful trial. We are not a “one size fits all” CRO.